JIN MEDICAL employs about 269 people. The company is managed by 2 executives with a total tenure of roughly 628 years, averaging almost 314.0 years of service per executive, having 134.5 employees per reported executive. Inspection of JIN MEDICAL's management performance can provide insight into the company performance.
JIN
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
JIN MEDICAL Management Team Effectiveness
The company has return on total asset (ROA) of 0.0578 % which means that it generated a profit of $0.0578 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1302 %, meaning that it created $0.1302 on every $100 dollars invested by stockholders. JIN MEDICAL's management efficiency ratios could be used to measure how well JIN MEDICAL manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to 0.14 this year. Return On Capital Employed is expected to rise to 0.26 this year. At this time, JIN MEDICAL's Return On Assets are quite stable compared to the past year. Asset Turnover is expected to rise to 0.92 this year, although the value of Net Tangible Assets will most likely fall to about 13.8 M.
JIN MEDICAL INTERNATIONAL is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 44,780. JIN MEDICAL maintains roughly 269 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19.
The output start index for this execution was zero with a total number of output elements of sixty-one. JIN MEDICAL INTERNATIONAL Price Series Summation is a cross summation of JIN MEDICAL price series and its benchmark/peer.
JIN MEDICAL Notable Stakeholders
A JIN MEDICAL stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as JIN MEDICAL often face trade-offs trying to please all of them. JIN MEDICAL's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting JIN MEDICAL's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
The success or failure of an entity such as JIN MEDICAL INTERNATIONAL often depends on how effective the management is. JIN MEDICAL management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of JIN management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the JIN management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Traditionally, organizations such as JIN MEDICAL use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare JIN MEDICAL within its industry.
JIN MEDICAL Manpower Efficiency
Return on JIN MEDICAL Manpower
Revenue Per Employee
87.4K
Revenue Per Executive
11.8M
Net Income Per Employee
12.7K
Net Income Per Executive
1.7M
Working Capital Per Employee
95.4K
Working Capital Per Executive
12.8M
When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.676
Earnings Share
0.02
Revenue Per Share
0.15
Quarterly Revenue Growth
0.353
Return On Assets
0.0578
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.